Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 274

1.

Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers.

Sakurada T, Kawashima J, Ariyama S, Kani K, Takabayashi H, Ohno S, Kato S, Yakabi K.

Dig Endosc. 2012 Mar;24(2):93-9. doi: 10.1111/j.1443-1661.2011.01176.x.

PMID:
22348833
2.

Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.

Tomita T, Kim Y, Yamasaki T, Okugawa T, Kondo T, Toyoshima F, Sakurai J, Tanaka J, Morita T, Oshima T, Fukui H, Hori K, Watari J, Matsumoto T, Miwa H.

J Gastroenterol Hepatol. 2012 Sep;27(9):1441-6. doi: 10.1111/j.1440-1746.2012.07144.x.

PMID:
22497427
3.

A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.

Yamaguchi Y, Katsumi N, Tauchi M, Toki M, Nakamura K, Aoki K, Morita Y, Miura M, Morozumi K, Ishida H, Takahashi S.

Aliment Pharmacol Ther. 2005 Jun;21 Suppl 2:111-5.

4.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

5.

Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.

Lau JY, Sung JJ, Lee KK, Yung MY, Wong SK, Wu JC, Chan FK, Ng EK, You JH, Lee CW, Chan AC, Chung SC.

N Engl J Med. 2000 Aug 3;343(5):310-6.

6.

Appropriate use of intravenous proton pump inhibitors in the management of bleeding peptic ulcer.

Julapalli VR, Graham DY.

Dig Dis Sci. 2005 Jul;50(7):1185-93. Review.

PMID:
16047458
7.
8.

Effect of famotidine on recurrent bleeding after successful endoscopic treatment of bleeding peptic ulcer.

Kamada T, Hata J, Kusunoki H, Kido S, Hamada H, Aoki R, Nishida T, Komoto K, Todo H, Sumioka M, Tanimoto T, Sanuki E, Sumii K, Ogoshi H, Hidaka T, Dongmei Q, Chayama K, Haruma K.

Aliment Pharmacol Ther. 2005 Jun;21 Suppl 2:73-8.

9.

[Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers].

Evseev MA, Ivakhov GB, Golovin RA.

Khirurgiia (Mosk). 2009;(3):46-52. Russian. No abstract available.

PMID:
19391208
10.
11.

Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer.

Gisbert JP, González L, Calvet X, Roqué M, Gabriel R, Pajares JM.

Aliment Pharmacol Ther. 2001 Jul;15(7):917-26.

12.

Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer.

Javid G, Masoodi I, Zargar SA, Khan BA, Yatoo GN, Shah AH, Gulzar GM, Sodhi JS.

Am J Med. 2001 Sep;111(4):280-4.

PMID:
11566458
13.

Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection.

Tsai JJ, Hsu YC, Perng CL, Lin HJ.

Br J Clin Pharmacol. 2009 Mar;67(3):326-32. doi: 10.1111/j.1365-2125.2008.03359.x.

14.

Comparison of hemostatic effects by route of H2 receptor antagonist administration following endoscopic mucosal resection in patients with neoplastic gastric lesions.

Satoh K, Yamamoto H, Kawata H, Osawa H, Hanatsuka K, Kita H, Sunada K, Hirasawa T, Yoshizawa M, Ajibe H, Satoh Y, Sunada F, Sugano K.

Aliment Pharmacol Ther. 2005 Jun;21 Suppl 2:105-10.

15.

Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.

Kantorova I, Svoboda P, Scheer P, Doubek J, Rehorkova D, Bosakova H, Ochmann J.

Hepatogastroenterology. 2004 May-Jun;51(57):757-61.

PMID:
15143910
16.

Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding.

Liu N, Liu L, Zhang H, Gyawali PC, Zhang D, Yao L, Yang Y, Wu K, Ding J, Fan D.

J Gastroenterol Hepatol. 2012 Sep;27(9):1473-9. doi: 10.1111/j.1440-1746.2012.07191.x.

PMID:
22646140
17.

Omeprazole versus histamine H2 receptor antagonists in the treatment of acute upper non-variceal bleeding.

Mohamed SA, al Karawi MA.

Hepatogastroenterology. 1996 Jul-Aug;43(10):863-5.

PMID:
8884305
19.

Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis.

Kusunoki H, Kusaka M, Kido S, Yamauchi R, Fujimura Y, Watanabe Y, Kobori M, Miwa H, Tomita T, Kin Y, Hori K, Tano N, Sugimoto K, Nakamura Y, Fujimoto K, Oza N, Matsunobu A, Ono N, Fuyuno S, Kinoshita Y, Adachi K, Yuki M, Fujisawa T, Haruma K.

J Gastroenterol. 2009;44(4):261-70. doi: 10.1007/s00535-009-0003-4.

PMID:
19280112
20.

The short-term medical management of non-variceal upper gastrointestinal bleeding.

Kovacs TO, Jensen DM.

Drugs. 2008;68(15):2105-11. Review.

PMID:
18840002
Items per page

Supplemental Content

Support Center